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االلتزام باألدوية بني مرضى السكري من النوع 2 يف ثالث واليات يف حمافظة 
الداخلية، عمان
دراسة ارتيادية مستعرضة
بينا جيمي، جيمي جو�س، زينب علي الهنائية، اإنت�صار خمي�س واداير، غالية حمد العامرية
abstract: Objectives: This pilot study aimed to assess the medication adherence of type 2 diabetes mellitus 
(T2DM) patients in three wilayats (districts) of the Al Dakhliyah governorate, Oman, and to identify the probable 
reasons for medication non-adherence. Methods: A cross-sectional questionnaire-based pilot survey was 
conducted among T2DM Omani patients between February and June 2012 to assess their medication adherence 
and the relationship between their socio-demographic characteristics and adherence levels. Results: A total of 158 
patients participated in the survey. The majority of the participants were unemployed or were housewives (66.5%). 
Forgetfulness was the most frequent reason for medication non-adherence (36.4%). Participants demonstrated an 
excellent level of adherence to their medicines (median total score = 3). No significant difference in median total 
adherence scores was observed based on the evaluated parameters. Conclusion: The medication adherence of 
T2DM patients in the area under study was good. A larger study in a wider population is warranted to obtain a more 
representative picture of this important factor which contributes to public health.
Keywords: Diabetes Mellitus, Type 2; Medication Adherence; Cross-Sectional Study; Oman. 
امللخ�س: الهدف: تهدف هذه الدرا�صة التجريبية لتقييم مدى التزام مر�صى ال�صكري النوع 2 بالدواء يف ثلث وليات من حمافظة الداخلية 
ولتحديد الأ�صباب املحتملة لعدم التزام مر�صى ال�صكري النوع 2 باأخذ الدواء. الطريقة: مت القيام مب�صح جتريبي مقطعي عن طريق توزيع 
ا�صتبيان على مر�صى ال�صكري النوع 2 خلل الفرتة ما بني فرباير ويونيو 2012 لتقييم مدى التزامهم باأدويتهم والعلقة بني اخل�صائ�س 
الجتماعية الدميوغرافية ومدى اللتزام باأخذ الدواء. النتائج: من جمموع 158 مري�صًا �صاركو يف الدرا�صة، معظم امل�صاركني من العاطلني 
عن العمل و ربات بيوت)%66.5( .الن�صيان كان ال�صبب الأكرث تكرارا لعدم اللتزام بالدواء)%36.4(. امل�صاركون كانوا ملتزمني بدرجة 
عالية باأدويتهم )متو�صط الدرجة الكلية = 3(. مل يلحظ اأي فرق ملمو�س يف متو�صط درجات اللتزام بالن�صبة ملدة املر�س اأو عدد الأدوية. 
النتيجة: التزام مر�صى ال�صكري النوع 2 بالأدوية يف املناطق التي حتت الدرا�صة كان جيدا. من املهم اإجراء درا�صة مو�صعه ت�صمل عدد اأكرب 
من ال�صكان للح�صول على نتائج اأكرث متثيل وو�صوحا عن هذا العامل املهم الذي ي�صهم يف ال�صحة العامة.
مفتاح الكلمات: مر�س ال�صكري؛ النوع 2؛ اللتزام بالدواء؛ درا�صة مقطعية م�صتعر�صة؛ عمان.
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BRIEF COMMUNICATION
Adherence to a medication regimen is generally defined as the extent to which patients take medications as prescribed by 
their healthcare providers.1 It is one of the major factors 
that determines therapeutic outcomes, especially 
in patients suffering from chronic illnesses. Low 
medication adherence has become a key healthcare 
issue as it greatly affects the benefits of medical care 
and imposes a significant financial burden on the 
individual patient and healthcare system as a whole.2 
It has been observed that the average adherence to 
long-term therapy for chronic illnesses in developed 
countries is only 50%.1 Adherence rates for patients 
with type 2 diabetes mellitus (T2DM) range from 
65–85% for oral agents and 60–80% for insulin.3 Many 
factors are potentially related to adherence problems, 
including demographics, the psychological and social 
status of the patient, the type of healthcare provider 
and medical system and other disease and treatment-
related factors.4
A study conducted by Al Moosa et al. in Oman 
shows that rising rates of diabetes and associated risk 
factors have been observed in populations undergoing 
epidemiological transition and urbanisation.5 Another 
study conducted in Oman shows that the prevalence 
of diabetes mellitus (DM) is on the rise and that there 
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are high rates of diabetes-related complications.6 More 
than 14% of people with DM in Oman were found 
to have diabetic retinopathy and 27% of those with 
T2DM had microalbuminuria.7,8
Although there have been some studies on the 
quality of diabetes care, there is a paucity of published 
data on medication adherence among the diabetic 
population in Oman.9,10 Of the studies conducted in 
the Middle East, non-compliance with medications 
was reported by 10% of diabetic patients in the United 
Arab Emirates (UAE).11 Poor practices of taking 
medications in relation to meals and modifying doses 
when necessary were reported among Qatari patients 
with DM12 and the level of diabetes knowledge among 
Kuwaiti adults with T2DM was poor.12,13 Hence, this 
cross-sectional pilot study was conducted to assess 
the medication adherence of T2DM patients in three 
wilayats (districts) of the Al Dakhliyah governorate 
of northern-central Oman and to determine their 
opinions on the probable reasons for medication 
non-adherence. The association between socio-
demographic characteristics and adherence levels was 
also investigated.
Methods
A cross-sectional questionnaire-based pilot 
study was conducted during the period February to 
June 2012 in Bid Bid, Nizwa and Bahla, which are 
three wilayats of the Al Dakhliyah governorate of 
Oman. The Research Committee of the College of 
Pharmacy & Nursing of the University of Nizwa 
approved the study’s research and ethical components. 
A questionnaire was developed for the study based 
on the parameters to be evaluated and themes from 
previous studies.14,15
Considering an Omani population of 269,069 in 
the Al Dakhliyah governorate for the year 2011 and 
the prevalence of DM to be 12% in Oman, a target 
population of 33,200 was assumed, the estimated 
population diagnosed with DM.16,17 Based on this 
target population, an appropriate sample size of 150 
was estimated with a confidence level of 95% and an 
interval of 8.
Three investigators visited houses in the study 
sites to enquire about residents potentially diagnosed 
with DM. These investigators were undergraduate 
students in pharmacy and co-authors of the 
study. All of them were involved in preparing the data 
collection tool and they were trained specifically in 
data collection by the two other co-authors, faculty 
members in pharmacy. The three investigators 
conducted the data collection independently in the 
three wilayats selected for the purpose of the study. 
Potential participants were identified and, with the 
help of the study information sheet, asked if they were 
willing to participate in the study. Those who were 
willing to participate and sign the informed consent 
form were enrolled for the study based on the inclusion 
and exclusion criteria. A convenience sampling method 
was adopted, taking into consideration the inherent 
difficulty in using other sampling methods to identify 
and enroll the diabetic patients from their households. 
Potential participants were selected from households 
rather than from a healthcare setting so as to reduce 
the chance of exaggeration in self-reported adherence, 
which is common when patients are interviewed in a 
healthcare setting.
T2DM patients between 35–70 years old and 
having been on anti-diabetic medication(s) for at 
least six months were included in the study. Patients 
who were debilitated or had any disease affecting 
their cognition and those who were not willing to 
participate were excluded. The questionnaire was 
completed by the participant in most of the cases (158 
out of 192) and the investigator was available for any 
clarification on the questionnaire. Even though the 
majority of participants in the study had not received 
a formal education, they were not completely illiterate, 
having learnt to read and write from madrassa, the 
Islamic school where the Holy Quran is learnt. The 
questionnaire was completed by the investigator or the 
patient’s relative for those few of the participants who 
had not received any education.
The questionnaire consisted of three parts. The 
first part collected information on the participants’ 
knowledge of their prescribed anti-diabetes 
medications, such as its proper dosage and the 
frequency and time of administration with regard 
to food. It also had questions to evaluate patients’ 
adherence to their medications and their reasons 
for non-adherence. The second part was designed 
to obtain information on the duration of each 
patient’s DM and its management. The third part 
was designed to capture the demographic details of 
the participants. The questionnaire was prepared in 
English and translated into Arabic. Content validity 
was assessed by another expert who was not involved 
in the preparation of the data collection instrument. It 
was pre-tested with 10 prospective respondents. An 
Arabic study information and informed consent form 
was also developed.
The reported adherence to dose, frequency and 
administration of medicine with regard to food of the 
individual patients was compared with the instructions 
on the medication prescription or label from the 
healthcare provider. A score of 1 was given if adherence 
was observed and 0 if there was no adherence to these 
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individual parameters. A total median adherence score 
was obtained by combining the individual scores for 
dose, frequency and administration. Accordingly, a 
maximum score of 3 was obtained for patients who 
adhered to all three parameters of dose, frequency and 
administration with regard to food, and a minimum 
score of 0 was obtained if they did not adhere to any 
of the parameters. This total median score was related 
to the demographics of the patient and the disease and 
medication details.
The results were analysed using the Statistical 
Package for the Social Sciences (SPSS), Version 
15 (IBM, Corp., Chicago, Illinois, USA) while the 
Mann-Whitney U and Kruskal-Wallis tests were used 
for continuous variables for non-parametric data 
depending on the number of comparative groups. A P 
value of <0.05 was considered statistically significant.
Results
A total of 158 completed questionnaires were obtained 
from the 192 questionnaires distributed, giving a 
response rate of 82.3%. Most of the respondents were 
female (60.1%) and a slightly higher percentage of 
participants were 46–60 years old (38%) [Table 1]. The 
majority of them had received no formal education 
(55.7%) and were unemployed or were housewives 
(66.5%). 
Many of them had been diagnosed with DM 
approximately 2–15 years before the study period 
[Table 2]. Most of the participants were taking 
either one (54.4%) or two (43%) drugs to control 
their DM [Table 2]. An evaluation of participants’ 
most likely reasons for non-adherence indicated 
that ‘forgetting to take’ their medication was the 
most frequent reason (36.4%) preventing optimal 
adherence to their prescribed drug regimen 
[Table 3]. Upon evaluation of the patients’ 
understanding of their medication regimen, it 
was observed that the vast majority of them (80%) 
understood their medication orders as instructed by 
their doctors.
The median total score of adherence with regard 
to dose, frequency and taking medicine before or 
after food, was 3 out of the maximum score of 3, 
which demonstrates an excellent level of patient 
adherence to their medicines. Upon evaluation of the 
association of the median total adherence score and 
demographics of participants, no significant difference 
was observed for gender, age, educational qualification 
or employment status. The median total adherence 
scores were evaluated to determine their relationship 
to other parameters such as number of years with DM 
and the number of diabetic medications prescribed. 
No significant difference was observed between 
median total adherence score and the number of years 
the patient had suffered from DM or the number of 
medications prescribed.
Table 1: Relationship of median total adherence score 
with demographics of respondents





Male 63 (39.9) 3 (1.0)  
0.235
Female 95 (60.1) 3 (0.5)
Age group in years
30–45 53  (33.5) 3 (1.0)  
 
0.99146–60 60  (38.0) 3 (1.0)
61–75 45  (28.5) 3 (1.0)
Educational qualification






Primary school 23 (14.6) 3 (0.5)
Secondary school 25 (15.8) 3 (0.0)
Higher secondary 17 (10.7) 3 (1.0)
Higher education 5 (3.2) 3 (1.0)
Employment status




Self-employed 19 (12.0) 3 (1.5)
Unemployed/
Housewife 105 (66.5) 3 (0.75)
IQR = interquartile range.
Table 2: Relationship of median total adherence score 
with disease and drug details








17 (10.8) 3 (0.0)
0.287
2–9 years 56 (35.4) 3 (1.0)
10–15 years 58 (36.7) 3 (1.0)
≥15 years 27 (17.1) 3 (1.0)
Number of anti-diabetic medications used
1 86 (54.4) 3 (1.0)  
 
0.3462 68 (43.1) 3 (1.0)
≥3 4 (2.5) 3 (0.75)
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Discussion
Medication adherence has a great impact on outcomes 
in chronic diseases. However, as many chronic 
disease patients often do not experience noticeable 
symptoms, following treatment recommendations 
can be difficult. Presently, there is no single measure 
accepted as the gold standard to measure medication 
adherence as all of the commonly employed methods 
have disadvantages. Patient interviews, while 
straightforward and inexpensive, are clearly limited by 
their subjective nature.18 This study was designed with 
the consideration that no previous published studies 
had assessed medication adherence among Omani 
patients with DM.
A total of 158 self-administered questionnaires 
from patients with T2DM were evaluated as a part 
of this study. The results showed that compliance 
levels were similar in male and female participants as 
well as among various age groups. A lack of significant 
association between compliance practice scores 
related to DM and gender and age was similarly 
observed in a study conducted in the UAE.13 In contrast, 
studies conducted in Uganda19 and Saudi Arabia20 
showed a significant association of compliance with 
the female gender and education levels. One factor 
that might contribute to medication adherence is 
the influence of employment status since those who 
are working have a higher tendency towards non-
adherence due to work schedules.
The social norms in countries like Oman mean 
that males are generally the primary income-earning 
members of the family. The majority of participants in 
this study were unemployed older men who were more 
likely to be retired. Hence, the combined influence of 
gender and work status might not have a significant 
influence on adherence as reported by the study 
participants. The number of years since participants 
had been diagnosed with DM did not affect levels of 
adherence in the present study. Similar results were 
found in a study in Saudi Arabia.20 This findings would 
seem to contradict the idea that patients with a longer 
history of the disease would be keener to adhere to 
their medications since complications would have 
developed, or that they would have a greater awareness 
and fear of developing them.
Unlike other studies where the cost of medication 
was reported as a reason for non-adherence, only a 
small proportion of patients in this study reported 
this as a reason for failing to follow medication 
guidelines.14,19 This is a reflection of Oman’s healthcare 
system, which is dedicated to maintaining the health 
of all citizens and thereby improving their quality of 
life. The financial burden of the disease does not affect 
Omani patients due to the availability of free medical 
care, including medications. This might also have 
influenced the absence of any significant relationship 
between the number of years since the diabetes 
diagnosis and the adherence level among participants 
in the study.
As was found in a study by Richard et al., the 
number of anti-diabetic drugs prescribed to a patient 
did not affect the participants’ medication adherence 
scores.21 Forgetting to take medications was the 
most frequently given reason for failing to adhere 
to treatment guidelines. It is of note that a large 
percentage of participants believed that missing one 
dose would not cause any problem, which highlights 
the importance of the need for counselling by 
healthcare professionals.
The study results reveal good patient adherence 
overall to the medication regimen in areas such as 
dose, frequency and following instructions as to 
administration. This positive reported adherence 
could be attributed to many factors, including good 
communication between patients and healthcare 
professionals; patients’ knowledge of the disease and 
awareness of its complications; the availability of 
medicines free of cost through government healthcare 
facilities, and the convenient availability and location 
of healthcare facilities.
The current study has some limitations. The 
sample size was small, which makes it difficult to 
generalise the results. It was difficult to identify and 
enroll patients in the manner used here as compared 
to recruiting a study population within a healthcare 
facility; hence, the quota sampling was challenging. 
The use of convenience sampling has its own inherent 
disadvantages. Further, the patients’ levels of adherence 
were self-reported, which needs to be taken into 
account when interpreting the results. However, to 
reduce any tendency to over-report adherence to the 
regimen, the potential participants were selected from 
households rather than from healthcare institutions, 
as exaggerated self-reported adherence is greatest 
when patients are interviewed in healthcare settings.
Table 3: Most common reasons for patient medication 
non-adherence
Reason Number of 
participants (%)
Forgetting to take 79 (36.4)
Missing one dose is not an issue 32 (14.7)
I feel I am fine 23 (10.6)
Too many medicines 23 (10.6)
Side-effects 19 (8.7)
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Conclusion
Overall, the findings from the present study indicate 
that the medication adherence of T2DM patients in the 
Al Dakhliyah Governorate of Oman is good. However, 
this finding should be interpreted with caution as the 
data is based on self-reported measures of adherence. 
Nonetheless, this study gives insight into the various 
factors that affect patient adherence to medication 
guidelines among an Omani patient population; these 
factors should be targeted by healthcare professionals. 
Awareness of these factors will allow healthcare 
professionals to be more effective in their medication 
counselling and patients to become more self-
responsible in adhering to a medication regimen.
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